Total Funding
59
47
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
141875
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
- Rob van Maanen: Chief Medical Officer
- Edouard Bieth: Chief Business Officer
About the Company
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.
Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies
to the growing number of patients in need that have limited or no treatment options.
To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
